Our findings are consistent with those from the only other study of liver cancer and IGF-1, in which patients with HCC were found to have significantly lower IGF-I levels than age- and gender-matched controls after adjusting for prothrombin time and serum albumin levels, indicators of the degree of liver damage (Stuver et al, 2000). The gene discussed is F2; the disease is hepatocellular carcinoma.